Ocular Therapeutix (OCUL) Misses Q1 EPS by 2c

Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.40), $0.02 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal